HSE to consider access to weight loss drug Mounjaro
A decision by a HSE expert group to approve the drug Mounjaro could be "transformative", according to Professor Donal O'Shea, a consultant endocrinologist and the HSE clinical lead in the National Obesity Programme.
We haven't written up this one. RTE News has the full story — the link below goes straight to it.